Open AccessClinical trials in retinal dystrophies
Author(s) -
Seanna Grob,
Avni P. Finn,
Thanos D. Papakostas,
Dean Eliott
Publication year - 2016
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.173135
Subject(s) - medicine , transformative learning , retinal , clinical trial , optometry , neuroscience , engineering ethics , ophthalmology , pathology , psychology , engineering , pedagogy
Research development is burgeoning for genetic and cellular therapy for retinal dystrophies. These dystrophies are the focus of many research efforts due to the unique biology and accessibility of the eye, the transformative advances in ocular imaging technology that allows for in vivo monitoring, and the potential benefit people would gain from success in the field - the gift of renewed sight. Progress in the field has revealed the immense complexity of retinal dystrophies and the challenges faced by researchers in the development of this technology. This study reviews the current trials and advancements in genetic and cellular therapy in the treatment of retinal dystrophies and also discusses the current and potential future challenges.